Edwards Lifesciences

PriceEdwards Lifesciences

EW

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Historical stock price chart and annual return over the past years

12%

5 years

% Total

EW
2%

5 years

Annual Return

EW